TerminatedPhase 3

Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population

United States200 participantsStarted 2008-03

Plain-language summary

In women with singleton gestations, to contemporarily assess the efficacy of oral nifedipine versus intravenous magnesium sulfate in the acute management of preterm labor in terms of defined early and late neonatal measures

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Cervix \> 2 cm in dilation or 80% effaced
✓. Positive fetal fibronectin (if performed).
✓. Demonstrated cervical change between two exams within 90 minutes.

What they're measuring

1

In women with singleton gestations, to contemporarily assess the efficacy of oral nifedipine versus intravenous magnesium sulfate in the acute management of preterm labor in terms of defined early and late neonatal measures

Timeframe: At delivery

Trial details

NCT IDNCT00641784

SponsorMemorialCare

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-03